Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus

American Journal of Gastroenterology

Volumn 100, Issue 1, 2005, Pages 21-26

  Amano, Yuji ^a   Kushiyama, Yoshinori ^b   Ishihara, Shunji ^b   Yuki, Takafumi ^b   Miyaoka, Youichi ^b   Yoshino, Nagisa ^b   Ishimura, Norihisa ^b   Fujishiro, Hirofumi ^b   Adachi, Kyoichi ^b   Maruyama, Riruke ^b   Rumi, Mohammad Azharul Karim ^b   Kinoshita, Yoshikazu ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET; METHYLENE BLUE; COLORING AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHROMOENDOSCOPY; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STAINING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ESOPHAGOSCOPY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MUCOSA; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; COLORING AGENTS; ESOPHAGOSCOPY; FEMALE; GENTIAN VIOLET; HUMANS; MALE; MASS SCREENING; METHYLENE BLUE; MIDDLE AGED; MUCOUS MEMBRANE; SENSITIVITY AND SPECIFICITY;

EID: 13744255682     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40028.x     Document Type: Article

References (35)

1. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Gastroenterology 1990;99:918-22.
2. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
3. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
4. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
5. Sharma P, Morales TG, Bhattacharyya A, et al. Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-6.
6. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:613-34.
7. Reid BJ, Blount PL, Feng Z, et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high grade dysplasia. Am J Gastroenterol 2000;95:3089-96.
8. Canto MI, Setrakian S, Petras RE, et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;44:1-7.
9. Canto MI, Setrakian S, Willis J, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000;51:560-8.
10. Sharma P, Topalovski M, Mayo MS, et al. Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest Endosc 2001;54:289-93.
11. Kiesslich R, Hahn M, Herrmann G, et al. Screening for specialized columnar epithelium with methylene blue: Chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 2001;53:47-52.
12. Dave U, Shousha S, Westaby D. Methylene blue staining: Is it really useful in Barrett's esophagus? Gastrointest Endosc 2001;53:333-5.
13. Lee JI, Park H, Jung H-Y, et al. Prevalence of Barrett's esophagus in urban Korean population: A multicenter study. J Gastroenterol 2003;38:23-7.
14. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003;38(Suppl):25-30.
15. Kudo S, Hirota S, Nakajima T, et al. Colorectal tumours and pit pattern. J Clin Pathol 1994;47:880-5.
16. Kudo S, Kashida H, Tamura T, et al. Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J Surg 2000;24:1081-90.
17. Amano Y, Komazawa Y, Ishimura N, et al. Two cases of superficial Barrett's cancer: Crystal violet chromoendoscopy for detecting lesions. Gastrointest Endosc 2004;59:143-6.
18. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
19. Amano K, Adachi K, Katsube T, et al. Role of hiatus hearnia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001;16:132-6.
20. Endo T, Asakawa T, Takahashi H, et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 2002;55:641-7.
21. Goldblum JR. Barrett's esophagus and Barrett's-related dysplasia. Mod Pathol 2003;16:316-24.
22. Van Niekerk CC, Jap PHK, Raemakers FCS, et al. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol 1991;165:145-52.
23. Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas: A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
24. Ormsby AH, Goldblum JR, Rice TW, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999;30:288-94.
25. Ormsby AH, Vaezi MF, Richer JE, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000;119:683-90.
26. Kouklakis GS, Kountouras J, Dokas SM, et al. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort. Endoscopy 2003;35:383-7.
27. Gangarosa LM, Halter S, Mertz H. Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low grade dysplasia. Dig Dis Sci 2000;45:225-9.
28. Breyer HP, Silva De Barros SG, Maguilnik I, et al. Does methylene blue detect intestinal metaplasia in Barrett's esophagus? Gastrointest Endosc 2003;57:505-9.
29. Wo JM, Ray MB, Mayfield-Stokes S, et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: A preliminary study. Gastrointest Endosc 2001;54:294-301.
30. Egger K, Werner M, Meining A, et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2003;52:18-23.
31. Canto MI, Setrakian S, Willins JE, et al. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: An in vivo and ex vivo study. Endoscopy 2001;33:391-400.
32. Courvelard A, Cauvin JM, Goldfain D, et al. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 2001;49:761-6.
33. Jovanovic I, Tzardi M, Mouzas M, et al. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol Histopathol 2002;17:445-54.
34. Guelrud M, Herrera I, Essenfeld H, et al. Enhanced magnification endoscopy: A new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53:559-65.
35. Sharma P, Weston AP, Topalovski M, et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003;52:24-7.